In breast cancer, RGS10 is downregulated in heavily metastatic human breast cancer cell populations compared to weakly metastatic human breast cancer cell populations (Montel et al., 2005; Steeg, 2005). This evidence concerns the gene RGS10 and breast carcinoma.